InMed: InMed Pharmaceuticals: InMed Announces Results of 2024 Annual General Meeting
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline o...
Read full article »
InMed is a Canada-based biopharmaceutical company that researches and develops cannabinoids for the treatment of glaucoma and Alzheimer’s diseases.
Read more